PeptiDream Inc.
Basic information
- Head office
- 〒210-0821 Kanagawa Prefecture, Kawasaki City, Kawasaki-ku, Tonemachi 3-25-23
- Chief executive
- Lead Patrick
- Capital
- Employees (non-consolidated)
- Employees (consolidated)
- 751 people
- Start date
- 2006-07-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
| PeptiAID Inc. | ||||||||
|
|
Network
History
Founded in Chiyoda Ward, Tokyo, with Yuaki Suga (developer of Flexizyme technology and professor at the University of Tokyo) and Kazuichi Kubota (former chairman of the board), with laboratories inside the University of Tokyo's Center for Advanced Science and Technology![]()
Acquired exclusive implementation and licensing rights with sublicense rights to Flexizyme and related basic patents from the University of Tokyo, a national university corporation![]()
Entered into a sub-licensable exclusive license agreement with the University of Tokyo on Flexizyme Technology![]()
Acquired exclusive implementation and licensing rights with sublicense rights to basic patents related to Flexizyme development from the State University of New York![]()
Entered into a sub-licensable exclusive license agreement with the State University of New York on Flexizyme Technology![]()
Relocated headquarters to Meguro Ward, Tokyo (inside the University of Tokyo's Center for Advanced Science and Technology)![]()
Relocated corporate headquarters to RCAST (Research Center for Advanced Science and Technology, The University of Tokyo)![]()
Relocated headquarters and laboratory functions to Meguro Ward, Tokyo (inside the University of Tokyo's Komaba Research Campus KOL)![]()
Relocated corporate headquarters and research laboratories to Komaba Research Campus, The University of Tokyo![]()
Established Peptide Discovery Platform System (PDPS), a proprietary drug discovery platform technology![]()
Relocated headquarters and research institute from Meguro Ward, Tokyo (inside the University of Tokyo's Komaba Research Campus KOL) to a new building within the Kings Sky Front, Kawasaki City, Kanagawa, an international strategic hub![]()
Lead Patrick, one of the founding members, who established the foundation technology of PDPS and supervised various research and development programs with pharmaceutical companies as CSO (Chief Science Officer), appointed as President and CEO![]()
PeptiStar Inc. was founded through a joint venture agreement between PeptiDream Inc., Shionogi & Co., Ltd. and Sekisui Chemical Co., Ltd.![]()
Established Peptigrow Co., Ltd., a joint venture with Mitsubishi Corporation to develop, manufacture, and sell peptides that substitute growth factors, essential components of cell culture media![]()
PeptiGrowth Inc. was founded through a joint venture agreement between PeptiDream Inc. and Mitsubishi Corporation.![]()
Established Peptieid Co., Ltd., a joint venture with Fujitsu Limited, Mizuho Capital Co., Ltd., Takenaka Corporation, and Kishida Chemical Co., Ltd., for the development of COVID-19 therapeutic drugs![]()
PeptiAID Inc. was founded through a joint venture agreement between PeptiDream Inc., Fujitsu Limited, Mizuho Capital Co., Ltd., Takenaka Corporation and KISHIDA CHEMICAL CO., LTD.![]()
Acquired PDR Pharma Inc., a new company that inherited the radioactive pharmaceuticals business through a spin-off from Fujifilm Toyama Chemical Co., Ltd.![]()
News
There is no news.